Showing results (121-130 of 731) with videos related to
Sort By:
Pageof 74
Nature|September 20, 2013
The causes and consequences of genetic heterogeneity in cancer evolutionRebecca A Burrell, Nicholas McGranahan, Jiri Bartek, et al.Genome Medicine|November 26, 2013
Intra-tumor heterogeneity: lessons from microbial evolution and clinical implicationsElza C de Bruin, Tiffany B Taylor, Charles SwantonJAMA|October 20, 2025
Lung Cancer in Nonsmoking Individuals: A ReviewCian Murphy, Tej Pandya, Charles Swanton, et al.The EPMA Journal|June 29, 2012
Personalization of prostate cancer prevention and therapy: are clinically qualified biomarkers in the horizon?Timothy A Yap, Charles Swanton, Johann S de BonoCell|January 28, 2021
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibitionKevin Litchfield, James L Reading, Clare Puttick, et al.Nature Machine Intelligence|May 28, 2026
Immunotherapy drug target identification using machine learning and patient-derived tumour explant validationMarcellus Augustine, Nuno Rocha Nene, Hongchang Fu, et al.Expert Opinion on Pharmacotherapy|April 29, 2014
New RAF kinase inhibitors in cancer therapyJuan Martin-Liberal, James LarkinFuture Oncology (London, England)|February 17, 2015
Vemurafenib for the treatment of BRAF mutant metastatic melanomaJuan Martin-Liberal, James LarkinMelanoma Management|September 8, 2018
Advances in immunotherapy for melanomaPaolo A Ascierto, James LarkinJournal of the National Cancer Institute|February 4, 2016
Immunotherapy Combined or Sequenced With Targeted Therapy in the Treatment of Solid Tumors: Current PerspectivesMichael B Atkins, James LarkinPageof 74